Aberdeen Group’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$502K Sell
14,148
-638
-4% -$22.6K ﹤0.01% 883
2025
Q1
$502K Sell
14,786
-16,732
-53% -$568K ﹤0.01% 872
2024
Q4
$1.03M Sell
31,518
-2,211
-7% -$72.1K ﹤0.01% 821
2024
Q3
$1.63M Buy
33,729
+17,696
+110% +$854K ﹤0.01% 770
2024
Q2
$710K Buy
16,033
+2,464
+18% +$109K ﹤0.01% 837
2024
Q1
$761K Sell
13,569
-2,132
-14% -$120K ﹤0.01% 842
2023
Q4
$945K Buy
15,701
+2,441
+18% +$147K ﹤0.01% 841
2023
Q3
$891K Sell
13,260
-2,343
-15% -$157K ﹤0.01% 769
2023
Q2
$1.08M Buy
15,603
+2,702
+21% +$187K ﹤0.01% 787
2023
Q1
$622K Sell
12,901
-664
-5% -$32K ﹤0.01% 823
2022
Q4
$677K Buy
13,565
+3,990
+42% +$199K ﹤0.01% 809
2022
Q3
$391K Buy
9,575
+4,222
+79% +$172K ﹤0.01% 863
2022
Q2
$295K Buy
+5,353
New +$295K ﹤0.01% 909